SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as traders anticipate Phase 3 HOPE-3 data, a potential catalyst for the heavily shorted stock. Discussions revolve around potential data leaks, a possible short squeeze, and the implications of the results for Duchenne muscular dystrophy (DMD) treatment. The community is closely watching for any news, with some expressing concerns about past disappointments and others hoping for a significant price surge if the data is positive.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending as investors discuss its potential following a surge in robotaxi revenue and increased institutional interest, including recent share purchases by ARK Invest and a Buy rating from Bank of America. Community members are highlighting the company's global expansion, particularly the launch of fully driverless robotaxi services in Abu Dhabi through Uber. Discussions also involve comparing WeRide's technology and market strategy with competitors like Pony.ai, and anticipating further catalysts by year-end.

Bondex is a web 3.0 professional network where users own part of the ecosystem earn rewards and monetise their network.

Bondex

Bondex ($BDXN) is trending with significant volume and price movement, especially after a recent token unlock event that the market absorbed well. The community is actively discussing its strong performance relative to other tokens and the potential for further gains, highlighting positive technical indicators. Bondex's focus on Web3 talent networking and recent acquisitions are also fueling interest.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is experiencing significant volatility, driven by news of a manufacturing milestone for its nasal spray product. Community chatter revolves around potential short squeezes and dilution concerns, as the stock demonstrates wild price swings and halts. Traders are actively discussing entry and exit points, with some anticipating a multi-day run while others foresee a sharp decline.

Gitlab, Inc. provides code hosting and collaboration platform services. It offers continuous integration, source code management, out-of-the-box pipelines, agile development, and value stream management. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in Dover, DE.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending amidst discussions of a potential acquisition by Datadog, reportedly at a price over $60 per share, though neither company has confirmed the takeover.  The community is weighing the potential deal, with some analysts expressing skepticism, and debating whether GitLab is undervalued, with some suggesting the stock should be worth significantly more. Despite the unconfirmed rumors, GitLab's strong revenue growth and AI integration remain key points of discussion.

American Eagle Outfitters, Inc. is a multi-brand specialty retailer, which offers an assortment of apparel and accessories for men and women under the American Eagle Outfitters brand, and intimates, apparel and personal care products for women under the Aerie brand. The firm operates stores in the United States, Canada, Mexico, Hong Kong, China and the United Kingdom. It also acquired two emerging brands to complement its existing brands, Tailgate, a vintage sports-inspired apparel brand, and Todd Snyder New York, a premium menswear brand. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is trending after releasing Q3 earnings that beat expectations, leading to a surge in stock price and increased Q4 guidance. The community is focused on holiday sales projections, gross margin improvements, and the continued impact of celebrity endorsements like Sydney Sweeney and Travis Kelce. The stock is also gaining attention as a potential anti-woke investment in the retail sector.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana's stock is trending due to positive earnings and guidance, with the company achieving cash flow positivity, which is a key talking point among investors. Community members are focused on the potential for a breakout, fueled by bullish options activity and the belief that the market has not yet priced in the company's improved financials. Broader discussions include the company's certifications for global compliance and its unique FedRAMP authorization.

Kohl's Corp. engages in the operation of family-oriented department stores. Its business line includes apparel, footwear, and accessories for women, men, and children, home products, beauty products, and accessories. The stores generally carry a consistent merchandise assortment with some differences attributable to regional preferences. The company was founded in 1962 and is headquartered in Menomonee Falls, WI.

Kohl`s Corp.

Kohl's Corp

$KSS is trending due to a surprise profit and raised guidance, leading to a significant surge and talk of a potential short squeeze. Community discussions revolve around whether the rally is sustainable, the impact of a new CEO, and the possibility of a further squeeze. Some investors believe $KSS is undervalued, while others remain skeptical about its long-term prospects.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its community rallies around the revival of OG memes and a return to grassroots community building within the crypto space. Discussions highlight the importance of consistent effort and belief in the project's vision, even amidst market volatility. The community is actively promoting its meme platform and expressing anticipation for broader market improvements, particularly expecting potential catalysts to come from macro events and Bitcoin's performance.

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. CervoMed, Inc. was founded in1995 and is headquartered in Boston, MA.

CervoMed Inc

CervoMed ($CRVO) is trending due to positive Phase 2b trial data for its DLB treatment, showing significant cognitive improvement and reduced neurodegeneration markers. While some investors are optimistic about the drug's potential and analysts' price targets, others express concern about potential dilution and the stock's volatile price action following the news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ENPH 
https://investor.enphase.com/news-releases/news-release-details/enphase-energy-introduces-powermatch-technology-europe-deliver

Turre

Im_Out

FREMONT, Calif. , Dec. 02, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of PowerMatch™ technology in Europe .

Enphase Energy

Enphase Energy Introduces PowerMatch Technology in Europe to Deliver More Usable Battery Energy and Savings | Enphase Energy

StockTwits for iOS

Enphase Energy Inc

stephan

@samwasco2007 Very nice! This is building on the distributed architecture of microinverters, which enables switching off microinverters that are not used momentarily.

 Very nice! This is building on the distributed architecture of microinverters, which enables switching off microinverters that are not used momentarily.